• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在高凝或低凝患者中,凝血酶生成以内源性凝血酶潜能来评估。

Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.

作者信息

Chantarangkul Veena, Clerici Marigrazia, Bressi Caterina, Giesen Peter L A, Tripodi Armando

机构信息

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy.

出版信息

Haematologica. 2003 May;88(5):547-54.

PMID:12745274
Abstract

BACKGROUND AND OBJECTIVES

The endogenous thrombin potential (ETP) represents the balance between pro- and anti-coagulant forces operating in plasma and can be used to investigate hyper- and hypo-coagulability. As a preliminary step to larger clinical studies we investigated the effect on ETP of phospholipids, tissue factor (TF) and residual platelets in frozen plasma.

DESIGN AND METHODS

We investigated platelet-poor and platelet-rich plasmas from healthy subjects, patients on oral anticoagulants (OA), or with hemophilia and women on oral contraceptives (OC), chosen as examples of the normal, hypo- and hyper-coagulable states in which ETP has been reported to be impaired.

RESULTS

Phospholipids had only a slight effect on ETP in all conditions except in women on OC, in whom the best diagnostic efficacy was observed at 0.5 microM. TF had only a slight effect in all conditions except hemophilia, in which an ETP impairment was observed only at low (1 pM) concentration. Residual platelets had considerable effects on ETP in frozen plasmas, but this was abrogated by filtration before freezing. ETP in platelet-rich plasma at 150x103/mm3 was similar to that obtained in filtered-plasma with 1.5 microM phospholipids in healthy subjects, patients on OA and patients with severe hemophilia, but not in those with mild- or moderate-hemophilia, where the ETP was higher in platelet-rich plasma.

INTERPRETATION AND CONCLUSIONS

The results suggest that the method can be used for investigations on the clinical value of ETP. Platelet-rich and platelet-poor plasma are suitable testing materials. The latter should be filtered before freezing to minimize the effect of residual platelets.

摘要

背景与目的

内源性凝血酶潜力(ETP)代表了血浆中促凝和抗凝力量之间的平衡,可用于研究高凝和低凝状态。作为更大规模临床研究的初步步骤,我们研究了冷冻血浆中磷脂、组织因子(TF)和残余血小板对ETP的影响。

设计与方法

我们研究了健康受试者、口服抗凝剂(OA)患者、血友病患者以及口服避孕药(OC)的女性的少血小板血浆和富血小板血浆,这些被选为据报道ETP受损的正常、低凝和高凝状态的示例。

结果

除服用OC的女性外,磷脂在所有情况下对ETP的影响都很小,在服用OC的女性中,在0.5微摩尔浓度时观察到最佳诊断效果。TF在所有情况下的影响都很小,除了血友病患者,在血友病患者中仅在低(1皮摩尔)浓度下观察到ETP受损。残余血小板对冷冻血浆中的ETP有相当大的影响,但在冷冻前通过过滤可消除这种影响。在健康受试者、服用OA的患者和重度血友病患者中,150×10³/mm³的富血小板血浆中的ETP与含有1.5微摩尔磷脂的过滤血浆中的ETP相似,但在轻度或中度血友病患者中并非如此,在这些患者中富血小板血浆中的ETP更高。

解读与结论

结果表明该方法可用于研究ETP的临床价值。富血小板血浆和少血小板血浆是合适的检测材料。后者在冷冻前应进行过滤,以尽量减少残余血小板的影响。

相似文献

1
Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.在高凝或低凝患者中,凝血酶生成以内源性凝血酶潜能来评估。
Haematologica. 2003 May;88(5):547-54.
2
The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability.内源性凝血酶潜力的常规测定,首先会导致不同形式的高凝和低凝状态。
Thromb Haemost. 1997 Apr;77(4):629-36.
3
Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.凝血因子和组织因子浓度对血浆凝血酶生成试验的影响。
Thromb Haemost. 2008 Apr;99(4):767-73. doi: 10.1160/TH07-09-0581.
4
Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.口服避孕药对通过校准自动血栓形成分析法测定的凝血酶生成的影响。
Thromb Haemost. 2007 Dec;98(6):1350-6.
5
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Haematologica. 2008 Apr;93(4):566-73. doi: 10.3324/haematol.12364. Epub 2008 Mar 5.
6
Platelets and phospholipids in tissue factor-initiated thrombin generation.组织因子启动的凝血酶生成中的血小板与磷脂
Thromb Haemost. 2001 Aug;86(2):660-7.
7
Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism.凝血酶生成:使用来自健康对照者以及有静脉血栓栓塞病史患者的乏血小板血浆、富血小板血浆和全血样本进行检测的比较
Br J Haematol. 2007 Oct;139(1):106-12. doi: 10.1111/j.1365-2141.2007.06732.x.
8
Evolving techniques for monitoring clotting in plasma and whole blood samples.用于监测血浆和全血样本中凝血情况的不断发展的技术。
Clin Lab. 2004;50(9-10):539-49.
9
Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.重度甲型血友病患者输注凝血因子 VIII 后的全血止血功能测定
Br J Haematol. 2007 Sep;138(6):775-82. doi: 10.1111/j.1365-2141.2007.06722.x. Epub 2007 Aug 2.
10
Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram.使用校准自动血栓图仪对表达组织因子的细胞进行体外凝血试验。
Lab Hematol. 2008;14(4):39-44. doi: 10.1532/LH96.08010.

引用本文的文献

1
Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance.重新审视血液离心对凝血酶生成测定参数的影响,以寻求对当前指南进行可能的修订。
Pract Lab Med. 2025 May 31;45:e00478. doi: 10.1016/j.plabm.2025.e00478. eCollection 2025 Jul.
2
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy.先天性出血性疾病患者的管理以及抗血栓治疗的心脏适应症
Eur Heart J Cardiovasc Pharmacother. 2025 May 2;11(3):275-289. doi: 10.1093/ehjcvp/pvaf006.
3
Testosterone Therapy Does Not Affect Coagulation in Male Hypogonadism: A Longitudinal Study Based on Thrombin Generation.
基于凝血酶原生成的男性性腺功能减退症的睾酮治疗并不影响凝血:一项纵向研究。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3186-3195. doi: 10.1210/clinem/dgae317.
4
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2.接种新冠病毒疫苗的健康受试者的参数及凝血激活均无变化。
Thromb Update. 2021 Aug;4:100059. doi: 10.1016/j.tru.2021.100059. Epub 2021 Jun 25.
5
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis.预测依库珠单抗预防治疗期间自发性关节出血的参数。
Blood Adv. 2024 Jun 11;8(11):2901-2907. doi: 10.1182/bloodadvances.2023012285.
6
Risk and adverse clinical outcomes of thrombocytopenia among patients with solid tumors-a Danish population-based cohort study.实体瘤患者血小板减少症的风险和不良临床结局:一项丹麦基于人群的队列研究。
Br J Cancer. 2024 May;130(9):1485-1492. doi: 10.1038/s41416-024-02630-w. Epub 2024 Mar 6.
7
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance.血友病患者的抗血栓治疗:欧洲血液学协会-国际血栓与止血学会-欧洲遗传性血管性水肿协会-欧洲血友病治疗协会临床实践指南
Hemasphere. 2023 Jun 5;7(6):e900. doi: 10.1097/HS9.0000000000000900. eCollection 2023 Jun.
8
Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Patients with Coagulation Factor 7 and 11 Deficiency and Atrial Fibrillation.经导管主动脉瓣植入术在伴有凝血因子 7 和 11 缺乏及心房颤动的二叶式主动脉瓣患者中的应用。
Anatol J Cardiol. 2023 Mar;27(3):173-175. doi: 10.14744/AnatolJCardiol.2022.2842.
9
Impact of anemia and thrombocytopenia on postpartum hemorrhage risk among women with term singleton pregnancy.贫血和血小板减少症对足月单胎妊娠妇女产后出血风险的影响。
J Thromb Thrombolysis. 2023 Apr;55(3):571-575. doi: 10.1007/s11239-022-02756-9. Epub 2023 Jan 2.
10
Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.非血液系统恶性肿瘤患者化疗引起的血小板减少症的治疗。
Haematologica. 2022 Jun 1;107(6):1243-1263. doi: 10.3324/haematol.2021.279512.